Altitudes: A Digital Intervention to Support Caregivers
Launched by UNIVERSITY OF NORTH CAROLINA, CHAPEL HILL · Jul 9, 2024
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
The Altitudes trial is looking at a new online support platform designed to help parents, caregivers, and supporters of young people dealing with psychosis. This platform aims to provide helpful resources and a space for caregivers to connect with each other, which may improve their well-being and reduce feelings of stress and burnout. Over the next six months, the study will involve up to 50 caregivers from different programs in North Carolina to see how easy it is for them to use the platform and how it affects their mental health and social support.
To participate in this trial, caregivers must be over 18 and currently support a young person receiving treatment for psychosis. This could be someone in a specialized care program, on a waiting list for help, or recently discharged from care. As part of the study, caregivers will need internet access and will provide feedback on their experiences using the platform. Overall, this trial aims to explore a supportive resource that could make a difference in the lives of those caring for young individuals with mental health challenges.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • The participants must be a parent, caregiver, or supporter of a young person who is currently receiving treatment from a CSC program for FEP or STEP clinic, on the waitlist to receive services from the CSC, who has recently graduated/discharged from a CSC program, or was referred to the study from the community (via Early Psychosis Interventions of North Carolina (EPI-NC) warm line, community psychiatrist/therapist, or inpatient/outpatient mental health services) where young person is experiencing psychosis but was not referred or enrolled in CSC
- • Parent, caregiver, or supporter must be \> 18 years of age
- • Participants recruited from NC CSC programs (i.e., OASIS, SHORE, Encompass, Eagle, AEGIS, WeCare2), STEP programs, and the community screening process
- • Parent, caregiver, or supporter must have access to internet through a mobile phone, tablet, or computer
- Exclusion Criteria:
- • Parent or caregiver is currently engaged in legal action against the loved one experiencing psychosis
- • Parent or caregiver does not speak and understand English as the platform, its moderation, interviews, and measures are available only in English
- • Parent, caregiver, or supporter is \<18 years of age
About University Of North Carolina, Chapel Hill
The University of North Carolina at Chapel Hill (UNC) is a leading research institution renowned for its commitment to advancing health and science through innovative clinical trials. With a robust infrastructure that supports multidisciplinary collaboration, UNC conducts cutting-edge research across various fields, including medicine, public health, and biomedical sciences. The university is dedicated to improving patient care and health outcomes by translating its research findings into practical applications. UNC’s clinical trials are designed to evaluate new therapies, interventions, and technologies, ensuring that they meet the highest ethical and scientific standards while fostering a culture of inclusivity and community engagement.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Chapel Hill, North Carolina, United States
Patients applied
Trial Officials
Kelsey R Ludwig, PhD
Principal Investigator
University of North Carolina, Chapel Hill
Diana Perkins, MD, MPH
Principal Investigator
University of North Carolina, Chapel Hill
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported